ES2063521T3 - Mezcla de sustancias con accion terapeutica constituida por compuestos de glutation y antociano. - Google Patents
Mezcla de sustancias con accion terapeutica constituida por compuestos de glutation y antociano.Info
- Publication number
- ES2063521T3 ES2063521T3 ES91914735T ES91914735T ES2063521T3 ES 2063521 T3 ES2063521 T3 ES 2063521T3 ES 91914735 T ES91914735 T ES 91914735T ES 91914735 T ES91914735 T ES 91914735T ES 2063521 T3 ES2063521 T3 ES 2063521T3
- Authority
- ES
- Spain
- Prior art keywords
- thio
- substances
- mixture
- antocian
- glutation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000000126 substance Substances 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title 1
- 229960003180 glutathione Drugs 0.000 abstract 3
- 235000003969 glutathione Nutrition 0.000 abstract 3
- LFNJHSYJNCVQTR-VGWMRTNUSA-N (2s)-2-[[[(1s)-1-carboxy-4-[[(2r)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-4-oxobutyl]-ethylamino]sulfanyloxysulfanyl-ethylamino]-5-[[(2r)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid Chemical compound OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(O)=O)N(CC)SOSN(CC)[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O LFNJHSYJNCVQTR-VGWMRTNUSA-N 0.000 abstract 1
- MTOYAHNULTYFRA-XUXIUFHCSA-N (2s)-2-[[[(1s)-1-carboxy-4-[[(2r)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-4-oxobutyl]-methylamino]sulfanyloxysulfanyl-methylamino]-5-[[(2r)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid Chemical compound OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(O)=O)N(C)SOSN(C)[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O MTOYAHNULTYFRA-XUXIUFHCSA-N 0.000 abstract 1
- HBQJTBXZMPSVBP-UHFFFAOYSA-N Cyanidine Natural products OC1=CC(=C2/Oc3cc(O)cc(O)c3C=C2O)C=CC1=O HBQJTBXZMPSVBP-UHFFFAOYSA-N 0.000 abstract 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 abstract 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
UNA MEZCLA DE SUSTANCIA PARA TRATAMIENTO TERAPEUTICO DEL CUERPO HUMANO O ANIMALES CONTIENE GLUTADION REDUCIDO Y AL MENOS UN COMPUESTO ANTOCIAN DEL GRUPO INTEGRADO POR PELARGONIDINA, PEONIDINA, CIANIDINA, MELVIDINA, PETUNIDINA Y DELFINIDINA. EL GLUTADION REDUCIDO PUEDE SER SUSTITUIDO DE FORMA COMPLETA O PARCIAL POR AL MENOS UN DERIVADO TIOL O GLUTADION DEL GRUPO INTEGRADO POR ETER METIL IONIL Y MONO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4026263 | 1990-08-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2063521T3 true ES2063521T3 (es) | 1995-01-01 |
Family
ID=6412534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES91914735T Expired - Lifetime ES2063521T3 (es) | 1990-08-20 | 1991-08-20 | Mezcla de sustancias con accion terapeutica constituida por compuestos de glutation y antociano. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0545972B1 (es) |
| JP (1) | JPH06503554A (es) |
| AT (1) | ATE113477T1 (es) |
| AU (1) | AU647820B2 (es) |
| BG (1) | BG61252B1 (es) |
| BR (1) | BR9106784A (es) |
| CA (1) | CA2088994C (es) |
| DE (1) | DE59103442D1 (es) |
| DK (1) | DK0545972T3 (es) |
| ES (1) | ES2063521T3 (es) |
| HK (1) | HK74597A (es) |
| HU (2) | HU223777B1 (es) |
| RU (1) | RU2093154C1 (es) |
| UA (1) | UA26442C2 (es) |
| WO (1) | WO1992003146A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9715444D0 (en) * | 1997-07-22 | 1997-09-24 | Scotia Holdings Plc | Therapeutic and dietary compositions |
| AU2175400A (en) * | 1998-12-11 | 2000-06-26 | Michigan State University | Method for the use of cherry isolates providing antioxidant phytoceutical or nutraceutical benefits |
| IT1304183B1 (it) * | 1998-12-18 | 2001-03-08 | Indena Spa | Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici. |
| AU3424500A (en) * | 1999-02-22 | 2000-09-14 | Gernot Treusch | Therapeutically active mixture of substances containing s-acetylglutathione and aciclovir |
| EP1074254A3 (en) * | 1999-07-20 | 2002-09-11 | MEDIS S.r.l. Medical Infusion Systems | Use of plant polyphenols with vitamines for treating iron overload |
| FR2809003B1 (fr) * | 2000-05-18 | 2003-01-24 | Oreal | Compositions anti-pollution a base d'anthocyanes |
| US7304210B2 (en) | 2001-09-07 | 2007-12-04 | Gain Harvest Development Ltd. | Raphanus with increased anthocyanin levels |
| EP1290938B1 (en) | 2001-09-07 | 2008-06-25 | Gain Harvest Development LTD | Raphanus with increased anthocyanin levels |
| KR100626850B1 (ko) * | 2003-04-04 | 2006-09-21 | (주)쎌믹스 | 흑미추출물을 이용한 알레르기성 질환 예방 또는 치료용조성물 및 이들의 치료학적 용도 |
| JP4247833B2 (ja) * | 2004-03-16 | 2009-04-02 | 株式会社ケーツーコミュニケーションズ | 視機能改善剤 |
| US7820207B2 (en) * | 2007-03-15 | 2010-10-26 | Omnica Gmbh | Stabilized anthocyanin compositions |
| US8623429B2 (en) | 2007-03-15 | 2014-01-07 | Omnica Gmbh | Stabilized anthocyanin compositions |
| FR2972327B1 (fr) * | 2011-03-11 | 2017-08-11 | Laboratoires Le Stum | Composition nutraceutique mucoadhesive comprenant une association d'antioxydants |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2740346C2 (de) * | 1976-09-08 | 1987-02-05 | Inverni Della Beffa S.P.A., Mailand/Milano | Pharmazeutische Zubereitung mit narbenbildender, Epithelium-regenerierender, entzündungshemmender, gefäßschützender, hypolipämischer, hypocholesterinämischer und/oder hypoglykämischer Wirkung |
| GB1589294A (en) * | 1976-09-08 | 1981-05-13 | Inverni Della Beffa Spa | Pharmaceutical compositions containing anthocyanidines |
| IT1200467B (it) * | 1985-05-06 | 1989-01-18 | Boehringer Biochemia Srl | Formulazione farmaceutica |
| DE3722647A1 (de) * | 1987-07-09 | 1989-01-19 | Gerhard Ohlenschlaeger | Galenische verwendung eines tripeptids als arzneimittel |
-
1991
- 1991-08-20 UA UA93004082A patent/UA26442C2/uk unknown
- 1991-08-20 CA CA002088994A patent/CA2088994C/en not_active Expired - Fee Related
- 1991-08-20 HU HU9300467A patent/HU223777B1/hu active IP Right Grant
- 1991-08-20 EP EP91914735A patent/EP0545972B1/de not_active Expired - Lifetime
- 1991-08-20 ES ES91914735T patent/ES2063521T3/es not_active Expired - Lifetime
- 1991-08-20 HU HU93467A patent/HUT63565A/hu unknown
- 1991-08-20 DE DE59103442T patent/DE59103442D1/de not_active Expired - Lifetime
- 1991-08-20 JP JP3513560A patent/JPH06503554A/ja active Pending
- 1991-08-20 DK DK91914735.5T patent/DK0545972T3/da active
- 1991-08-20 BR BR919106784A patent/BR9106784A/pt not_active Application Discontinuation
- 1991-08-20 AT AT91914735T patent/ATE113477T1/de not_active IP Right Cessation
- 1991-08-20 AU AU83345/91A patent/AU647820B2/en not_active Ceased
- 1991-08-20 WO PCT/EP1991/001580 patent/WO1992003146A1/de not_active Ceased
- 1991-08-20 RU RU9193005113A patent/RU2093154C1/ru not_active IP Right Cessation
-
1993
- 1993-03-17 BG BG97542A patent/BG61252B1/bg unknown
-
1997
- 1997-06-05 HK HK74597A patent/HK74597A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU8334591A (en) | 1992-03-17 |
| DE59103442D1 (de) | 1994-12-08 |
| HU223777B1 (hu) | 2005-01-28 |
| CA2088994A1 (en) | 1992-02-21 |
| UA26442C2 (uk) | 1999-08-30 |
| EP0545972B1 (de) | 1994-11-02 |
| BG97542A (bg) | 1994-03-24 |
| ATE113477T1 (de) | 1994-11-15 |
| HU9300467D0 (en) | 1993-05-28 |
| RU2093154C1 (ru) | 1997-10-20 |
| EP0545972A1 (de) | 1993-06-16 |
| BG61252B1 (en) | 1997-04-30 |
| AU647820B2 (en) | 1994-03-31 |
| HK74597A (en) | 1997-06-13 |
| JPH06503554A (ja) | 1994-04-21 |
| DK0545972T3 (da) | 1994-11-28 |
| WO1992003146A1 (de) | 1992-03-05 |
| HUT63565A (en) | 1993-09-28 |
| BR9106784A (pt) | 1993-06-29 |
| CA2088994C (en) | 2002-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1808488A (en) | Compounds for the treatment of alzheimer's disease | |
| DE10199020I2 (de) | Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit. | |
| IT8522574A0 (it) | Composizione farmaceutica eprocedimento per trattare il corpo umano con essa. | |
| SE8102194L (sv) | Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna | |
| BR9106784A (pt) | Mistura de substancias,terapeuticamente ativa,de compostos de glutationa e antociano | |
| FI901949A7 (fi) | Happoa kestävä FGF-koostumus ja menetelmä ruuansulatuskanavassa esiint yvien, haavaumia aiheuttavien sairauksien hoitamiseksi | |
| CS530585A2 (en) | Zpusob vyroby 2 substituovanych 1,3 propylidendifosfonatovych derivatu | |
| SE7902742L (sv) | Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav | |
| EP0455448A3 (en) | Treatment of pancreatic disease with 15-keto-prostaglandin compounds | |
| PT69525A (fr) | Installation de traite d'animaux en particulier des brebis | |
| ATE114157T1 (de) | Peptidverbindungen mit wachstumshormonfreisetzender aktivität. | |
| ES2085898T3 (es) | Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina. | |
| GR3006674T3 (es) | ||
| ES2113345T3 (es) | Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina. | |
| FI873429A7 (fi) | Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon. | |
| AU569354B2 (en) | (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane | |
| NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
| FI895229A7 (fi) | Yhdisteitä virtsan pidätyskyvyttömyyden hoitoon | |
| AU639322B2 (en) | Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds | |
| AR245225A1 (es) | Composiciones para el tratamiento de cuero. | |
| EP0312132A3 (en) | Veterinary and human medical remedy having an antiviral and antitumorous activity, containing 2,6-diamino-3-phenyl-azo-pyridine | |
| BR7001855U (pt) | Disposicao construtiva em tronco para o tratamento de bovinos | |
| ES512871A0 (es) | "procedimiento para el tratamiento de desperdicios". | |
| IT8722869V0 (it) | Dispositivo perfezionato per l'abbronzatura artificiale integrale o parziale. | |
| NO924701D0 (no) | Amid-bundete pyridyl-benzosyrederivater for behandling avleukotrien-relaterte sykdommer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 545972 Country of ref document: ES |